PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Conditions
Lupus Nephritis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Purushotham & Akther Kotha MD, Inc., La Mesa, California, United States
Contact: Study coordinator (Aurinia Clinical Trials Information) · clinicaltrials@auriniapharma.com · 833-606-5975Valerius Medical Group & Research Center of Greater Long Beach, Inc., Los Alamitos, California, United States
Contact: Study coordinator (Aurinia Clinical Trials Information) · clinicaltrials@auriniapharma.com · 833-606-5975Swati Shah MD Rheumatology, LLC, Jacksonville, Florida, United States
Contact: Study coordinator (Aurinia Clinical Trials Information) · clinicaltrials@auriniapharma.com · 833-606-5975CTR Oakwater, Orlando, Florida, United States
Contact: Study coordinator (Aurinia Clinical Trials Information) · clinicaltrials@auriniapharma.com · 833-606-5975Parris and Associates Rheumatology, Lawrenceville, Georgia, United States
Contact: Study coordinator (Aurinia Clinical Trials Information) · clinicaltrials@auriniapharma.com · 833-606-5975Accurate Clinical Research, Inc., Lake Charles, Louisiana, United States
Contact: Study coordinator (Aurinia Clinical Trials Information) · clinicaltrials@auriniapharma.com · 833-606-5975Arthritis and Osteoporosis Consultants of the Carolinas, Charlotte, North Carolina, United States
Contact: Study coordinator (Aurinia Clinical Trials Information) · clinicaltrials@auriniapharma.com · 833-606-5975Joint and Muscle Research Institute, Charlotte, North Carolina, United States
Contact: Study coordinator (Aurinia Clinical Trials Information) · clinicaltrials@auriniapharma.com · 833-606-5975West Tennessee Research Institute, Jackson, Tennessee, United States
Contact: Study coordinator (Aurinia Clinical Trials Information) · clinicaltrials@auriniapharma.com · 833-606-5975Novel Research LLC, Bellaire, Texas, United States
Contact: Study coordinator (Aurinia Clinical Trials Information) · clinicaltrials@auriniapharma.com · 833-606-5975Liberty Research Center, Dallas, Texas, United States
Contact: Study coordinator (Aurinia Clinical Trials Information) · clinicaltrials@auriniapharma.com · 833-606-5975Integrative Rheumatology of South Texas, Harlingen, Texas, United States
Contact: Study coordinator (Aurinia Clinical Trials Information) · clinicaltrials@auriniapharma.com · 833-606-5975Northwest Houston Arthritis Center, Houston, Texas, United States
Contact: Study coordinator (Aurinia Clinical Trials Information) · clinicaltrials@auriniapharma.com · 833-606-5975Texas Rheumatology Research Institute, LLC, Plano, Texas, United States
Contact: Study coordinator (Aurinia Clinical Trials Information) · clinicaltrials@auriniapharma.com · 833-606-5975Nephrology Leaders and Associates, PLLC, Van Vleck, Texas, United States
Contact: Study coordinator (Aurinia Clinical Trials Information) · clinicaltrials@auriniapharma.com · 833-606-5975